Prophylaxe venöser Thromboembolien in der nicht-operativen Medizin
- 26 September 2025
- book chapter
- Published by Springer Nature
- p. 1125-1130
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort studyJournal of Thrombosis and Haemostasis, 2020
- The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2019
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)Cochrane Database of Systematic Reviews, 2014
- Heparin Thromboprophylaxis in Medical-Surgical Critically Ill PatientsCritical Care Medicine, 2013
- Traveller’s thrombosis: International consensus statementVasa, 2008
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- Venous Thrombosis After Long-haul FlightsArchives of internal medicine (1960), 2003
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Risk Factors for Venous Thrombotic DiseaseThrombosis and Haemostasis, 1999